Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$551.30+4.6%$456.77$425.00▼$616.00$188.93B1.612.70 million shs4.01 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical+4.61%+26.85%+23.13%+11.18%+7.55%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$551.30+4.6%$456.77$425.00▼$616.00$188.93B1.612.70 million shs4.01 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical+4.61%+26.85%+23.13%+11.18%+7.55%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.63Moderate Buy$604.509.65% UpsideCurrent Analyst Ratings BreakdownLatest ISRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/23/2025ISRGIntuitive SurgicalUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetNeutral$585.00 ➝ $600.0010/23/2025ISRGIntuitive SurgicalHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$595.00 ➝ $644.0010/23/2025ISRGIntuitive SurgicalRothschild & Co RedburnSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$610.00 ➝ $615.0010/22/2025ISRGIntuitive SurgicalMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$575.0010/22/2025ISRGIntuitive SurgicalTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$525.00 ➝ $620.0010/22/2025ISRGIntuitive SurgicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOutperform$615.00 ➝ $625.0010/22/2025ISRGIntuitive SurgicalRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOutperform$592.00 ➝ $603.0010/22/2025ISRGIntuitive SurgicalRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$655.0010/22/2025ISRGIntuitive SurgicalJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$550.00 ➝ $560.0010/22/2025ISRGIntuitive SurgicalWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$599.00 ➝ $600.00(Data available from 10/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$8.35B23.66$8.36 per share65.97$47.54 per share11.60Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.32B$7.5672.9272.255.5328.58%15.08%13.38%N/ALatest ISRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/21/2025Q3 2025ISRGIntuitive Surgical$1.99$2.40+$0.41$1.95$2.41 billion$2.51 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A4.974.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%Insider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical15,638358.48 million355.97 millionOptionableISRG HeadlinesRecent News About These CompaniesIntuitive Surgical (NASDAQ:ISRG) Stock Price Up 13.9% on Better-Than-Expected Earnings1 hour ago | americanbankingnews.comIntuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters.October 23 at 7:10 PM | barrons.comBuy the Post-Earnings Surge in Intuitive Surgical (ISRG) Stock?October 23 at 5:30 PM | zacks.comIntuitive Surgical (NASDAQ:ISRG) Shares Up 4.6% Following Analyst UpgradeOctober 23 at 4:54 PM | marketbeat.comTraders Buy High Volume of Call Options on Intuitive Surgical (NASDAQ:ISRG)October 23 at 1:59 PM | marketbeat.comIntuitive Surgical, Inc. (NASDAQ:ISRG) Q3 2025 Earnings Call TranscriptOctober 23 at 12:06 PM | msn.comIntuitive Surgical, Inc. (NASDAQ:ISRG) Short Interest Up 43.7% in SeptemberOctober 23 at 11:15 AM | marketbeat.comIntuitive Surgical Is A Buy Despite Post-Earnings SurgeOctober 23 at 10:31 AM | seekingalpha.comIntuitive Surgical’s Strong Q3 Performance and Future Growth Potential Justifies Buy RatingOctober 23 at 9:51 AM | tipranks.comIntuitive Surgical (NASDAQ:ISRG) Given New $560.00 Price Target at Jefferies Financial GroupOctober 23 at 9:32 AM | marketbeat.comIntuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, HSBC Analyst SaysOctober 23 at 9:32 AM | marketbeat.comIntuitive Surgical (NASDAQ:ISRG) Price Target Raised to $615.00 at Rothschild & Co RedburnOctober 23 at 9:32 AM | marketbeat.comIntuitive Surgical, Inc. $ISRG Shares Sold by Cadinha & Co. LLCOctober 23 at 9:31 AM | marketbeat.comKPP Advisory Services LLC Grows Holdings in Intuitive Surgical, Inc. $ISRGOctober 23 at 9:31 AM | marketbeat.comFirst Citizens Bank & Trust Co. Grows Position in Intuitive Surgical, Inc. $ISRGOctober 23 at 9:30 AM | marketbeat.comBleakley Financial Group LLC Increases Stake in Intuitive Surgical, Inc. $ISRGOctober 23 at 8:44 AM | marketbeat.comWhy Intuitive Surgical (ISRG) Is Up 21.0% After Record da Vinci 5 Growth and Strong Q3 ResultsOctober 23 at 7:05 AM | finance.yahoo.comBrookstone Capital Management Has $13.42 Million Stock Position in Intuitive Surgical, Inc. $ISRGOctober 23 at 6:12 AM | marketbeat.comIntuitive Surgical, Inc. 2025 Q3 - Results - Earnings Call PresentationOctober 23 at 2:00 AM | seekingalpha.comIntuitive Surgical (ISRG) Earnings Beat Reinforces Bullish Narratives, But Valuation Stays ExpensiveOctober 22 at 10:29 PM | finance.yahoo.comIntuitive Surgical’s Earnings Call Highlights Robust GrowthOctober 22 at 8:11 PM | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025October’s Top 5 Stocks Poised for Big BreakoutsBy Thomas Hughes | October 1, 2025Why Congress Is Buying Intuitive Surgical Ahead of EarningsBy Gabriel Osorio-Mazilli | October 14, 2025Is Intuitive Surgical the Hidden Winner in Healthcare’s Weakness?By Gabriel Osorio-Mazilli | October 1, 2025Why Intuitive Surgical Is a No-Brainer for Long-Term InvestorsBy Thomas Hughes | October 22, 2025ISRG Company DescriptionsIntuitive Surgical NASDAQ:ISRG$551.30 +24.27 (+4.61%) Closing price 10/23/2025 04:00 PM EasternExtended Trading$549.49 -1.81 (-0.33%) As of 10/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Capital One Just Flashed a Buy Signal—New Highs Could Be Next Why Intuitive Surgical Is a No-Brainer for Long-Term Investors Is Oracle’s AI Rally Over? Wall Street Thinks ORCL Could Hit $400 GM Posts Largest Gain Since the Pandemic: Shares Still Look Cheap 3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
